Symbol="MYGN"
AssetType="Common Stock"
Name="Myriad Genetics Inc"
Description="Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized, and prognostic medicine tests in the United States and internationally. The company is headquartered in Salt Lake City, Utah."
CIK="899923"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES"
Address="320 WAKARA WAY, SALT LAKE CITY, UT, US"
FiscalYearEnd="June"
LatestQuarter="2023-03-31"
MarketCapitalization="1845594000"
EBITDA="-84800000"
PERatio="None"
PEGRatio="1.11"
BookValue="10.25"
DividendPerShare="0"
DividendYield="0"
EPS="-1.77"
RevenuePerShareTTM="8.59"
ProfitMargin="-0.21"
OperatingMarginTTM="-0.207"
ReturnOnAssetsTTM="-0.0742"
ReturnOnEquityTTM="-0.164"
RevenueTTM="694700000"
GrossProfitTTM="476400000"
DilutedEPSTTM="-1.77"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.099"
AnalystTargetPrice="22.33"
TrailingPE="-"
ForwardPE="40.98"
PriceToSalesRatioTTM="2.15"
PriceToBookRatio="1.666"
EVToRevenue="2.224"
EVToEBITDA="-19.13"
Beta="1.785"
num_52WeekHigh="28.18"
num_52WeekLow="13.92"
num_50DayMovingAverage="21.8"
num_200DayMovingAverage="20.36"
SharesOutstanding="81555000"
DividendDate="None"
ExDividendDate="None"
symbol="MYGN"
open="22.69"
high="22.80"
low="22.04"
price="22.26"
volume="519625.00"
latest_trading_day="2023-07-18"
previous_close="22.63"
change="-0.37"
change_percent="-1.6350%"
aroon_positive_momentum_days="77"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="77"
Volume_recent_avg="587781"
Change_recent_avg="0.04"
Delta_recent_avg="0.94"
Variance_recent_avg="0.47"
Change_ratio_recent_avg="0.17"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="77"
Aroon_momentum_negative="23"
image_negative_thumbnail_id_1="1102"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0135.jpeg"
image_negative_thumbnail_id_2="120"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0056.jpeg"
image_neutral_thumbnail_id_1="552"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_neutral_thumbnail_id_2="584"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0015.jpeg"
image_positive_thumbnail_id_1="987"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0149.jpeg"
image_positive_thumbnail_id_2="699"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0009.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1192"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
